Company: RGBP
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001641172-25-011206
Chunk: 16

Company: Regen BioPharma Inc
Filing Date: 2025-05-16
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
 Stock, other series of
Preferred issued by Regen, and Series NC Preferred Stock shall vote as a single class on all matters submitted to the stockholders.

The holders of Series NC Preferred Stock shall be
entitled receive dividends, when, as and if declared by the Board of Directors in accordance with Nevada Law, in its discretion, from
funds legally available therefore

On any voluntary or involuntary liquidation, dissolution
or winding up of Regen, the holders of the Series NC Preferred Stock shall receive, out of assets legally available for distribution to
Regen’s stockholders, a ratable share in the assets of Regen.

On May 20, 2024 Regen Biopharma, Inc. amended its
Certificate of Incorporation adding the following Article 8 which is and reads as follows:

Shares of one class or series of stock may be issued
as a share dividend in respect of another class or series.

On May 21, 2024 the Board of Directors of Regen Biopharma,
Inc declared a dividend to all shareholders of record as of June 20,2024 (“ Record Date”) to be paid to shareholders on or
about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to
consist of two share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date,
every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred
Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series
NC Preferred Stock owned as of the Record Date.

On July 3, 20249,694,152Series A Preferred Shares
were issued as a dividend to the Shareholders of Record.

On September 18, 2024 the Board of Directors of Regen
Biopharma, Inc.(“ Regen”) declared a dividend to all shareholders of record as of October 17,2024 (“ Record Date”)
be paid to shareholders on November 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Common
Stock and to consist of one share of Common Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date,
every one share